Biomarkers to monitor the prognosis, disease severity, and treatment efficacy in coronary artery disease.
Armand N YazdaniMichaela PletschAbraham ChorbajianDavid ZitserVikrant RaiDevendra K AgrawalPublished in: Expert review of cardiovascular therapy (2023)
By utilizing the markers discussed, healthcare providers can improve patient care, optimize treatment plans, and ultimately reduce healthcare costs associated with CAD management.